http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-160000-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96ec3985e3ce9b24614fb87bf51a4f12
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2853
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
filingDate 2009-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b3a297bfc114ad7a86584685b94adcd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ef2d250d20e5dac6f800d2f301d076c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f17a42898f55216418a01c984042484f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0374b463bb96cc327179fbe6f36e837a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de9965bbeb03dcdc386e772c22328a1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_174f2113248c9ab5cba7f0facb32f60f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd60e82eca3964568657dac4a58d2731
publicationDate 2017-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-160000-A
titleOfInvention Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin ii antagonist and/or diuretic
abstract THE PRESENT INVENTION RELATES TO A PHARMACEUTICAL DOSAGE FORM COMPRISING AN ACTIVE INGREDIENT COMBINATION OF NIFEDIPINE OR NISOLDIPINE AND AT LEAST ONE ANGIOTENSIN II ANTAGONIST AND/OR AT LEAST ONE DIURETIC, CHARACTERIZED IN THAT NIFEDIPINE OR NISOLDIPINE IS RELEASED IN THE BODY IN A CONTROLLED (MODIFIED) MANNER AND THE ANGIOTENSIN II ANTAGONIST AND/OR THE DIURETIC IS RELEASED RAPIDLY (IMMEDIATE RELEASE (IR)), AND ALSO TO PROCESSES FOR THEIR PREPARATION, TO THEIR USE AS MEDICAMENTS AND TO THEIR USE FOR THE PROPHYLAXIS, SECONDARY PROPHYLAXIS OR TREATMENT OF DISORDERS.
priorityDate 2008-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425535208

Total number of triples: 41.